| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 08/28/2002 | EP0862454B1 Ctla-8 in combination with g-csf or with g-csf and il-6, and use of ctla-8 for treating infections |
| 08/28/2002 | EP0827591B1 Method for diagnosing chlamydia using an extracellular biological fluid |
| 08/28/2002 | EP0769064B1 A method for mass production of taxol by semi-continuous culture |
| 08/28/2002 | CN1089807C Method for producing L-aspartic acid |
| 08/28/2002 | CN1089606C Conjugate between modified superantigen and target-seeking compound and use of conjugate |
| 08/27/2002 | US6441138 Protein which induces interferon-γ production by immunocompetent cell |
| 08/27/2002 | US6440742 Recombinant AAV vector-based transduction system and use of same |
| 08/27/2002 | US6440712 Fermentation using as microorganism a polysaccharide negative yeast strain moniliella, concentrating the unrefined micro-organism-free fermentation culture medium to dry substance, crystallizing; purity, simplification |
| 08/27/2002 | US6440702 For treatment of motor neuron diseases and muscle degenerative diseases; screening for therapeutic proteins by determining altered electrophoretic binding properties |
| 08/27/2002 | US6440701 Transferrin receptor genes of Moraxella |
| 08/27/2002 | US6440680 Using dna encoding the novel prostaglandin receptor and host cells expressing the receptor |
| 08/27/2002 | US6440679 Dermatomyositis-specific auto-antigen |
| 08/27/2002 | US6440425 High molecular weight major outer membrane protein of moraxella |
| 08/27/2002 | US6440423 Mutant enterotoxin effective as a non-toxic oral adjuvant |
| 08/27/2002 | US6440418 Variable light and heavy amino acid sequences encoded by nucleic acid sequences; seq id no:24, 25 and 26; rheumatoid arthritis, multiple sclerosis, diabetes, and systemic lupus erythematosus; graft versus host disease; gene therapy |
| 08/27/2002 | US6440407 Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 (IL-3) multiple mutation polypeptides |
| 08/27/2002 | CA2264270C Mass production of paclitaxel by changing the temperature of the medium during the plant cell culture |
| 08/27/2002 | CA2231738C Stress resistant plant in which cell death suppressing gene is introduced and method for producing the same |
| 08/27/2002 | CA2125403C Novel tissue plasminogen activator variants |
| 08/27/2002 | CA2018592C Polypeptides and polypeptide analogues with inhibitory activity against human elastase |
| 08/22/2002 | WO2002064832A1 Method of examining allergic disease |
| 08/22/2002 | WO2002064808A1 Method for l-threonine production |
| 08/22/2002 | WO2002064800A1 Plasmid shuttle vector between escherichia coli and brevibacillus |
| 08/22/2002 | WO2002064784A2 Yeast strain of saccharomyces cerevisiae with functional expression of a glut transporter |
| 08/22/2002 | WO2002064624A2 Improved method for production of secreted proteins in fungi |
| 08/22/2002 | WO2001081920A3 Comparative phenotype analysis for assessment of biologically active compounds |
| 08/22/2002 | WO2000036092A9 METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-β RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION |
| 08/22/2002 | WO2000024907A9 Library of novel "unnatural" natural products |
| 08/22/2002 | WO1999058143A9 Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
| 08/22/2002 | US20020116733 Generating disease resistant plant sesds; obtain seeds, incubate with hypersensitive response protein, classify plants propagated from seeds |
| 08/22/2002 | US20020115834 New process for the production of biologically active protein |
| 08/22/2002 | US20020115597 Antibiotics GE 23077, pharmaceutically acceptable salts and compositions, and use thereof |
| 08/22/2002 | US20020115181 Enzymatic polypeptide for use in paper making and animal feeds |
| 08/22/2002 | US20020115152 Expression system for factor VIII |
| 08/22/2002 | US20020115110 Method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2 |
| 08/22/2002 | US20020114792 Alpha-2-macroglobulin therapies and drug screening methods for Alzheimer's disease |
| 08/22/2002 | CA2438356A1 Improved method for production of secreted proteins in fungi |
| 08/21/2002 | EP1233071A2 Organic nitrogen-containing composition and fertilizer comprising the same |
| 08/21/2002 | EP1233070A2 Method for producing L-glutamic acid |
| 08/21/2002 | EP1233069A2 Method for producing L-glutamic acid |
| 08/21/2002 | EP1233068A2 Method for producing L-glutamic acid |
| 08/21/2002 | EP1233067A1 Method for the fermentative production of O-acetyl-L-serine |
| 08/21/2002 | EP1233065A1 G-CSF analog compositions and methods |
| 08/21/2002 | EP1232268A2 Cytochrome p450 oxygenases and their uses |
| 08/21/2002 | EP0746618B1 A method of preparing a variant of a lipolytic enzyme |
| 08/21/2002 | EP0642580B1 Hepatocyte growth factor variants |
| 08/21/2002 | EP0537160B1 Expression of recombinant hemoglobin in yeast |
| 08/21/2002 | CN1365393A Novel cytochrome p450 monooxygenases and their use for oxidizing organic compounds |
| 08/21/2002 | CN1365390A A human lactoferrin produced by using insect cell and method using the same |
| 08/21/2002 | CN1365386A Engineering of metabolic control |
| 08/21/2002 | CN1365385A Purple photosynthetic bacteria and health foods |
| 08/21/2002 | CN1365284A Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 08/21/2002 | CN1089214C Yogourt |
| 08/20/2002 | US6437218 Altered epicuticular wax |
| 08/20/2002 | US6437114 Human dopamine receptor and uses |
| 08/20/2002 | US6437112 Dna encodes polypeptide of fusion protein or tail fiber proteins of bacteriophage t4 |
| 08/20/2002 | US6437111 Bone morphogenetic protein-11 (BMP-11) compositions |
| 08/20/2002 | US6437098 Genetic engineering; anticarcinogenic agents; side effect reduction |
| 08/20/2002 | US6436907 Adenovirus-medicated gene transfer to cardiac and vascular smooth muscle |
| 08/20/2002 | US6436888 α-amylase mutants |
| 08/20/2002 | US6436707 Trap cassette and splice acceptor; polyadenylation sequence defining 3' end of first exon; high speed screening; gene expression |
| 08/20/2002 | US6436693 Using dna helper virus vector dna mutated so that cis-acting signal sequences for packaging of dna are non-functional; helper virus dna may provide information necessary for production of viral particles but may not be packaged therein |
| 08/20/2002 | US6436691 Chemical compounds |
| 08/20/2002 | US6436664 Method for producing shikimic acid |
| 08/20/2002 | US6436661 Bacteria and bacteriophage detection using immobilized enzyme substrates |
| 08/20/2002 | US6436410 DNA encoding neospora dihydrofolate reductase-thymidylate synthase |
| 08/20/2002 | US6436408 Cold -adapted equine influenza viruses |
| 08/20/2002 | CA2203991C Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
| 08/20/2002 | CA2098404C Improved humanized immunoglobulins |
| 08/20/2002 | CA2059124C Platelet aggregation inhibitors |
| 08/20/2002 | CA2006865C Humanized immunoglobulins and their production and use |
| 08/20/2002 | CA1341384C Expression and diagnostic use of gag encoded peptides which are immunologically reactive with antibodies to lav |
| 08/15/2002 | WO2002062298A2 Pro-apoptotic bacterial vaccines to enhance cellular immune responses |
| 08/15/2002 | WO2001064899A3 Nucleotide sequences encoding proteins that take part in the biosynthesis of l-serine, improved method for microbially producing l-serine, and genetically modified microorganism suitable for use in said method |
| 08/15/2002 | WO2001034168A9 Inhibition of pathogens by bacillus coagulans strains |
| 08/15/2002 | WO1999064067A9 Vaccine |
| 08/15/2002 | US20020111472 T1-r ligand iii |
| 08/15/2002 | US20020111463 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 08/15/2002 | US20020111331 FGF-affinity chromatography |
| 08/15/2002 | US20020111299 Family of peptides known as xenoxins |
| 08/15/2002 | US20020110876 Method for producing threonine and isoleucine |
| 08/15/2002 | US20020110874 Recombinant production of novel polyketides |
| 08/15/2002 | US20020110873 Process for the production of lipstatin and tetrahydrolipstatin |
| 08/15/2002 | US20020110866 Nucleotide sequences coding viral capsid protein; for use in the diagnosis, treatment and/or vaccination |
| 08/15/2002 | US20020110865 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses |
| 08/15/2002 | US20020110840 Detecting modulators of interferon generation; obtain cells, incubate with modulator, monitor concentration of inflammatory cytokine, amplified cytokine concentration indicates modulators |
| 08/15/2002 | US20020110550 Using esterase activity enzyme selected from pepper esterase and porcine esterase for protection of plant against phytopathogenic fuigi, protects plant against phytopathogenic fungi by inhibition of fungal appressorium formation |
| 08/15/2002 | US20020110545 Adenovector pharmaceutical composition |
| 08/15/2002 | US20020108505 Production process for foodstuff fermenting agents |
| 08/15/2002 | CA2437596A1 Pro-apoptotic bacterial vaccines to enhance cellular immune responses |
| 08/15/2002 | CA2372133A1 Process for preparing 0-acetyl-l-serine by fermentation |
| 08/14/2002 | EP1231283A2 Method of differentiating beer yeast |
| 08/14/2002 | EP1231277A2 Biocompatible implant for in vivo formation of a neo-organ |
| 08/14/2002 | EP1231275A2 Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
| 08/14/2002 | EP1231274A2 Modified porteinase inhibitors |
| 08/14/2002 | EP1231217A2 Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
| 08/14/2002 | EP1230930A2 Bmp-9 compositions |
| 08/14/2002 | EP1230351A1 Fungamyl-like alpha-amylase variants |
| 08/14/2002 | EP1230347A1 Method for the preparation of purified hcv rna by exosome separation |
| 08/14/2002 | EP1230257A2 Expression of immunogenic hepatitis b surface antigens in transgenic plants |